CVE-2025-3826
Published: 20 April 2025
Summary
CVE-2025-3826 is a medium-severity Cross-site Scripting (CWE-79) vulnerability in Senior-Walter Web-Based Pharmacy Product Management System. Its CVSS base score is 4.8 (Medium).
Operationally, ranked at the 31.7th percentile by exploit likelihood (below the median); it is not currently listed in the CISA KEV catalog; a public proof-of-concept is referenced.
EU & UK References
- 🇪🇺 ENISA EUVD: EUVD-2025-15026
Vulnerability details
A vulnerability, which was classified as problematic, was found in SourceCodester Web-based Pharmacy Product Management System 1.0. This affects an unknown part of the file add-supplier.php. The manipulation of the argument txtsupplier_name/txtaddress leads to cross site scripting. It is possible…
more
to initiate the attack remotely. The exploit has been disclosed to the public and may be used.
- CWE(s)
Related Threats
No named actor attribution yet. ATT&CK technique mapping in progress for this CVE.
Affected Assets
Mitigating Controls
Likely Mitigating Controls AI
Per-CVE control mapping for this CVE has not run yet; the list below is derived from the weakness types (CWEs) cited in the NVD entry.
Validates web inputs to reject script-related content that could produce XSS.
Penetration testing submits XSS payloads to web applications, detecting cross-site scripting flaws for subsequent remediation.
Makes persistent code injection into loaded programs impossible when the executable image itself resides on hardware-protected read-only media.
Dynamically generated code can be produced and executed inside the isolated chamber, preventing host compromise from code-injection payloads.
Output validation against expected content can reject or sanitize script content in generated web pages, reducing XSS exploitability.
Directly prevents execution of attacker-supplied code written into data memory regions.